DSP Healthcare Fund led the three-month return chart in the healthcare sector, delivering 13.4% gains. While it outperformed rivals in the short term, investors should consider the longer-term consistency of funds like SBI Healthcare Opportunities Fund and the high risks associated with sectoral concentration.
The DSP Healthcare Fund has recorded a 13.4% return over the past three months, emerging as a top performer among healthcare and pharmaceutical sector mutual funds. This performance has placed the fund ahead of peers such as the SBI Healthcare Opportunities Fund, which recorded 12.1% returns, and the Mirae Asset Healthcare Fund, which delivered 7.6% during the same period. The analysis, based on data for funds with over Rs 1,500 crore in assets under management, highlights the sharp short-term gains achievable in the sector.
While DSP Healthcare Fund saw strong momentum in the recent three-month window, a broader view reveals that leadership often changes across different timeframes. The SBI Healthcare Opportunities Fund has demonstrated superior consistency, leading the pack over six-month, one-year, and three-year periods. For example, its three-year returns stood at 23.0%, underscoring the importance for investors to look beyond short-term snapshots when evaluating fund managers.
Investing in sectoral funds involves a different set of risks compared to diversified equity funds. Regulatory guidelines from SEBI require these schemes to invest at least 80% of their assets in pharmaceutical and healthcare companies. This mandatory focus creates high concentration risk, meaning the performance of the fund is tied directly to the health of a single industry. If the pharmaceutical sector faces headwinds, such as pricing controls, raw material cost pressures, or negative regulatory actions in key export markets like the United States, these funds can experience significant volatility.
Scale is another factor investors often track. Among the top-tier healthcare funds, the Nippon India Pharma Fund maintains the largest corpus, managing approximately Rs 9,279 crore. In comparison, the DSP Healthcare Fund manages a smaller asset base of roughly Rs 3,639 crore. Smaller fund sizes can sometimes allow for more agility in stock picking, but they may also be subject to higher liquidity constraints depending on the portfolio composition.
Financial experts suggest that recent gains in the healthcare sector may not be sustainable in the long run. The sector is highly sensitive to external policies and global supply chain shifts, which makes it inherently more volatile than broader market indices. Consequently, investors who choose to allocate to such thematic funds are generally advised to maintain a long-term investment horizon of 7 to 10 years to ride out cyclical downturns. The key monitorable for investors going forward remains the ability of the fund managers to navigate regulatory challenges and maintain consistency across varying market cycles.